Carmel Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Carmel Capital Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-79,454	Closed	-$1.15M	–	173
2024 Q2	$1.15M	Buy	79,454 +3,143	+4%	+$50.2K	0.48%	42
2024 Q1	$1.24M	Sell	76,311 -13,250	-15%	-$207K	0.51%	37
2023 Q4	$1.33M	Sell	89,561 -11,848	-12%	-$134K	0.68%	29
2023 Q3	$1.14M	Buy	101,409 +37,784	+59%	+$439K	0.51%	39
2023 Q2	$640K	Buy	63,625 +12,835	+25%	+$119K	0.33%	63
2023 Q1	$477K	Buy	50,790 +8,884	+21%	+$105K	0.28%	74
2022 Q4	$512K	Sell	41,906 -5,845	-12%	-$72.9K	0.35%	65
2022 Q3	$593K	Sell	47,751 -1,256	-3%	-$22K	0.57%	49
2022 Q2	$962K	Buy	49,007 +8,695	+22%	+$206K	0.9%	31
2022 Q1	$1.05M	Buy	40,312 +1,122	+3%	+$29.9K	0.88%	33
2021 Q4	$1.11M	Buy	+39,190	New	+$1.22M	0.83%	27

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Carmel Capital Partners's ELAN Position: Q3 2024 in Review

Carmel Capital Partners sold out of Elanco Animal Health (ELAN) in Q3 2024, closing a stake of 79,454 shares — an estimated $1.15M sold.

Carmel Capital Partners first reported a position in ELAN in Q4 2021 and held it in 11 quarters. The position peaked at $1.33M in Q4 2023. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

Carmel Capital Partners reported no remaining Elanco Animal Health position as of Q3 2024 after selling out during the quarter.
Carmel Capital Partners sold 79,454 Elanco Animal Health shares in Q3 2024, an estimated $1.15M.
Carmel Capital Partners first reported a position in Elanco Animal Health in Q4 2021 and held it in 11 quarters.
Carmel Capital Partners's Elanco Animal Health position peaked at $1.33M in Q4 2023.
388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on Carmel Capital Partners's 13F filing for Q3 2024, filed 1 Nov 2024.